Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02499952
Title Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nasser Hanna, M.D.
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.